Search alternatives:
system decrease » step decrease (Expand Search)
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
mm decrease » a decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
_ system » _ systems (Expand Search), _ systemic (Expand Search)
system decrease » step decrease (Expand Search)
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
mm decrease » a decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
_ system » _ systems (Expand Search), _ systemic (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Glucose depletion decreases SBPM.
Published 2019“…<b>C)</b> Only the metabolically active D-isoform of glucose (not L-glucose) can sustain a significantly higher SBPM in physiologically-relevant conditions containing 5mM D- or L-glucose, 5mM DL-lactate (racemic mixture) and 0.22mM pyruvate. …”
-
11
-
12
mGluR5 receptor decreased glycinergic currents.
Published 2019“…(<b>E</b>) The inhibitory effect of CHPG on GlyR-IPSCs was not blocked by intracellularly loaded GDP-β-S (62.3 ± 6.4% of baseline at 15–20 min post-CHPG, <i>t</i>[6] = 2.782, <i>p</i> = 0.032), chelerythrine (60.9 ± 11.3% of baseline at 15–20 min post-CHPG, <i>t</i>[6] = 2.705, <i>p</i> = 0.035), or Ro-32-0432 (69.9 ± 3.2% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 8.495, <i>p</i> < 0.001). (<b>F</b>) Postsynaptic loading of U-0126 or PD98059 prevented CHPG from decreasing glycinergic responses (U-0126, 107.6 ± 10.4% of baseline at 15–20 min post-CHPG, <i>t</i>[8] = 0.997, <i>p</i> = 0.348; PD98059, 93.1 ± 5.0% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 0.883, <i>p</i> = 0.418). …”
-
13
-
14
Refinement of scrambles, with no USM decreases.
Published 2022“…<p>Effects of guided substitutions within scrambled expert-designed proteins, when they are not permitted to decrease USM EC<sub>50</sub> predictions.</p> <p>(EPS)</p>…”
-
15
-
16
-
17
SLE decreases risk for hormonal cancers.
Published 2021“…(b) Prostate cancer incidence in male SLE cohort is significantly decreased by SLE status (OR 0.23, 95% CI 0.089, 0.50, p = 0.0053).…”
-
18
-
19
-
20